Suchergebnisse

Actualmente en el Estado español se están produciendo problemas en el suministro de medicamentos a los servicios farmacéuticos. En el presente artículo se revisa la normativa vigente acerca de la distribución de medicamentos. Se comentan además las posibles causas del problema. También se analizan los medios que desarrolla el Estado para evitar esta problemática y la postura de la Comunidad Valenciana que, de manera pionera, quiere regular en materia de distribución farmacéutica, mediante una normativa con rango de Ley, para evitar los problemas que se suscitan. ; In this paper, we discuss the problems arising from the current supply problems of medicines to pharmacy outlets in Spain, as well as a revision of present regulations governing their distribution. In addition to the possible causes, an analysis of the measures developed by the state to combat these problems has been made, as well as an assessment of the impact of new pioneering legislation passed by the regional government of Valencia, aimed at fi nding a solution.

Currently there are several cases in the field of the European Union regarding Spanish legislation on private pharmacy planning. The first of these cases was initiated by issuing a reasoned opinion by the European Commission on 28 June 2006. The second approach has taken place through the various preliminary questions raised before the Court of Justice of the European Communities by certain Spanish courts. Although not all of the above procedures have been completed, certain European pronouncements do provide what might be the consequences that they may have on the Spanish legislation on the subject. It is very likely that the binomial property-ownership in favor of pharmacists and planning criteria established in the Spanish regulations is considered compatible with European law. On the contrary, it is feasible that certain aspects of the merit scales applied by the Autonomous Communities for awarding newly authorized community pharmacies must be changed.